OKKO MASTERCLASS 360 PROGRAM - BEYOND 2020
Date: 15/03/2020
Venue: Brisbane Convention & Exhibition Centre, Cnr Merivale and Glenelg Streets South Bank, Brisbane, QLD, 4101
Provider: OKKO Eye Specialist Centre
Contact: Narelle Murphy, [E] info@okko.com.au, [P] 07 37250222
Learning Objectives
- Dr Lamb Lecture
1.Demonstrate the functional relevance of common eyelid complaints from patients and the symptoms they experience
2. Distinguishing a functional eyelid/brow problem from a cosmetic one.
What attracts a Medicare/Health fund rebate
3. The surgical treatment for common eyelid complaints from patients and the therapeutic prescribing issues associated, pre- , inta- and post operatively, problem and a cosmetic one
- Dr Toalster Lecture 1 Medication tips and tricks: prescribing for eye disease.
Learning Objectives
1. To develop a range of safe prescribing practices for common diseases presenting to optometric practice.
2. To understand which medication prescribing scenarios present a high risk of adverse events.
3. To develop a range of management strategies to deal with clinical scenarios or medication adverse outcomes
- Dr Toalster Lecture 2. Ocular surface cancer: new options for 2020.
Learning Objectives
1. Understand the range of sun related ocular surface changes and the influence of solar radiation on the risk of these developing.
2. Be able to recognise the features of ocular surface lesions which are associated with cancerous transformation.
3. Be able to describe the range of current and emerging treatment options for ocular surface neoplasia.
- Dr Matthew Russell Lecture.1. Refractive versus Standard Cataract Surgery: Myths and realities in 2020 and Beyond?
Key learning objectives are to
1. Understand the limitations of cataract surgery as a refractive procedure with current technologies.
2. Develop an awareness of the range of management options available. Emerging treatment options will also be discussed.
3. Discussed the therapeutic issues and patient counselling involved in pre-, intra- and post operative cataract surgery care
- Dr Matthew Russell Lecture. 2. Common Macular Conditions: Imaging, Current & Future Management
Key learning objectives are to
1. Understand the correlation between the clinical examination and OCT findings for common macula disorders
2. Understand the differential diagnosis of subretinal and intraretinal fluid within the macula.
3. Identify key macula conditions requiring urgent referral
- Dr Judy Ku Lecture 1. Lessons from “The Terminator” – Cornea repair & regeneration beyond 2020
Key learning objectives
i. To understand the benefits and limitations of current treatment for corneal injuries
ii. To have an overview of future regeneration technology in anterior segment healing
iii. To provide practical tips for optometrists in managing corneal injuries
- Dr Judy Ku Lecture 2. Glaucoma management, what does the future hold?
Learning objectives
1. To provide an update on current treatment trends in Primary Angle Closure Glaucoma
2. To introduce modern glaucoma medical treatment which is clinically applicable in the near future eg: ROCK inhibitors, iDose
3. To gain insight into the benefits and risks of various Glaucoma Surgical techniques
- Inez Hsing Lecture 1 Taking OCT Interpretation To The Next Level
LEARNING OBJECTIVES
1. Revise participants’ current understanding of OCT technology and interpretation
2. Demonstrate real-life application of OCT technology, including how this can enhance clinical and therapeutic management of patients in practice
3. Offer a brief introduction into emergent OCT-based technologies
- Inez Hsing Lecture 2: Taking Back 2020 – A Glaucoma Australia Update
LEARNING OBJECTIVES
1. Update participant’s on what Glaucoma Australia has achieved in the past year, and plans for the upcoming year
2. Offer insight into how Glaucoma Australia can assist with collaborative care between optometrists and ophthalmologists
3. Discuss issues involved in Therapeutic and surgical collaborative glaucoma care
- Simon Doble Lecture
Learning objectives
1. To understand the issues involved in addressing the unmet needs for adequate lighting for vision, education and social empowerment in the developing world in 2020 and beyond
2. To understand how the gift of lighting and good sight helps others to help themselves
3. To understand how Simon’s improved vision benefited Simon in his day-to-day life and his work in the global community
Max points awarded: Up To 19.00 14.75T inc
Session Information
Name |
---|
Refractive versus Standard Cataract Surgery: Myths and realities in 2020 and Beyond? |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
Yes |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
2.25 |
Name |
---|
Lessons from “The Terminator” – Cornea repair & regeneration beyond 2020 |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
Yes |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
1.5 |
Name |
---|
Droopy Lids & Eye Bags |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
Yes |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
2.25 |
Name |
---|
Keratitis - Medication tips and tricks: prescribing for eye disease |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
Yes |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
1.5 |
Name |
---|
Taking OCT Interpretation To The Next Level |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
Yes |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
2.00 |
Name |
---|
COVID-19: what you need to know
|
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
Yes |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
2.25 |
Name |
---|
Common Macular Conditions: Imaging, Current & Future Management |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
No |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
1.5 |
Name |
---|
Glaucoma Management: What Does The Future Hold? |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
Yes |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
2 |
Name |
---|
Ocular surface cancer: New Options for 2020 |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
Yes |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
1.00 |
Name |
---|
Taking back 2020: A Glaucoma Australia |
Activity Type |
---|
Face to Face with Assessment |
Therapeutic? |
---|
No |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
0.75 |
Name |
---|
SPEAKER Q&A PANEL DR TOALSTER, DR KU, DR RUSSELL, MS HSING |
Activity Type |
---|
Face to Face without Assessment |
Therapeutic? |
---|
No |
Manufacturer/Supplier? |
---|
No |
Points for attending & Passing Assessment |
---|
2.00 |
Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
---|
Refractive versus Standard Cataract Surgery: Myths and realities in 2020 and Beyond? | Face to Face with Assessment | Yes | No | 2.25 |
Lessons from “The Terminator” – Cornea repair & regeneration beyond 2020 | Face to Face with Assessment | Yes | No | 2.25 |
Droopy Lids & Eye Bags | Face to Face with Assessment | Yes | No | 2.25 |
Keratitis - Medication tips and tricks: prescribing for eye disease | Face to Face with Assessment | Yes | No | 2.25 |
Taking OCT Interpretation To The Next Level | Face to Face with Assessment | Yes | No | 2.25 |
2020 and beyond. The impact of one patient’s keratorefractive surgery on the global community | Face to Face with Assessment | No | No | 1.50 |
Common Macular Conditions: Imaging, Current & Future Management | Face to Face with Assessment | No | No | 2.25 |
Glaucoma Management: What Does The Future Hold? | Face to Face with Assessment | Yes | No | 2.25 |
Ocular surface cancer: New Options for 2020 | Face to Face with Assessment | Yes | No | 2.25 |
Taking back 2020: A Glaucoma Australia | Face to Face with Assessment | No | No | 1.50 |
SPEAKER Q&A PANEL DR TOALSTER, DR KU, DR RUSSELL, MS HSING | Face to Face without Assessment | No | No | 1.00 |